Press release – Results of phase III study with Treosulfan, EMA approval pending
Highly effective with reduced toxicity – Treosulfan-based regimen is a promising new conditioning therapy for MDS
and AML
Click here to view full Press release
Highly effective with reduced toxicity – Treosulfan-based regimen is a promising new conditioning therapy for MDS
and AML
Click here to view full Press release